Elroy Block

Finerenone Reduces T2D Onset in HF With Preserved EF

September 10, 2024

MADRID — The nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone reduced the incidence of new-onset type 2 diabetes by approximately 25%...

Elroy Block

Finerenone Reduces T2D Onset in HF With Preserved EF

First aid for heart attack: Cardiologist Deepak Krishnamurthy explains what to do | Watch

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

Budget FY25: Pharmaceuticals sector needs a major boost with increased focus on R&D and innovation

Dental veneers: Everything you need to know

Cheeky diet soft drink getting you through the work day? Here’s what that may mean for your health

UK teenagers get two-thirds of their calories from ultra-processed foods—new study

Some have called this area a birthing ‘desert.’ A nurse midwife is working to change that

First aid for heart attack: Cardiologist Deepak Krishnamurthy explains what to do | Watch

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories